Pfizer and BioNTech begin clinical trial for Omicron-specific vaccine :: WRAL.com
[ad_1] By Amanda Sealy, CNN CNN — Pfizer and BioNTech have begun a clinical trial for their Omicron-specific Covid-19 vaccine candidate, they announced in a news release on Tuesday. The study will evaluate the vaccine for safety, tolerability and the level of immune response, as both a primary series and a booster dose, in up […]
Continue Reading